Behavioral
Christopher Greater Area Rural Health Planning Corporation
Christopher Greater Area Rural Health Planning Corporation was paid $3.80M by Medicaid between Jan 2018 and Dec 2024, across 60 billing codes. Its largest line is T1015, a visit at a community health center or clinic (one all-in rate) — 100% of everything it billed.
33Billing provider infoCHRISTOPHER GREATER AREA RURAL HEALTH PLANNING CORPORATION
DU QUOIN, IL 62832
DU QUOIN, IL 62832
33aNPI1619957297assigned 01/19/2006
33bProvider typeCounselor
28Total paid$3.80M
24GClaims83,972
24DCodes billed60
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Counselor providers in Illinois
Rank by total paid#10 of 85
Median peer was paid$55K
This provider vs. median69×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 6,739 | $302K | |
| 2019 | 19,734 | $638K | |
| 2020 | 14,389 | $636K | |
| 2021 | 8,449 | $412K | |
| 2022 | 7,730 | $408K | |
| 2023 | 13,525 | $680K | |
| 2024incomplete | 13,406 | $723K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| T1015 | A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive | 100% | 35,571 | 27,441 | $3.80M |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 1,022 | 871 | $1K |
| 90670 | <1% | 140 | 109 | $215.33 | |
| 90723 | <1% | 69 | 49 | $79.15 | |
| 90647 | <1% | 64 | 50 | $26.23 | |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | <1% | 13,327 | 10,955 | $18.21 |
| 36415 | Collection of venous blood by venipuncture | 0% | 2,709 | 2,425 | $0.00 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 0% | 1,666 | 1,458 | $0.00 |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 0% | 10,213 | 8,398 | $0.00 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 0% | 109 | 109 | $0.00 |
| 84443 | Thyroid stimulating hormone (TSH) | 0% | 957 | 779 | $0.00 |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 0% | 2,156 | 1,779 | $0.00 |
48 more codes
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 0% | 589 | $0.00 |
| 80053 | Comprehensive metabolic panel | 0% | 2,440 | $0.00 |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 0% | 149 | $0.00 |
| 83036 | Hemoglobin; glycosylated (A1C) | 0% | 591 | $0.00 |
| 90834 | Psychotherapy session, about 45 minutes | 0% | 32 | $0.00 |
| 87807 | 0% | 84 | $0.00 | |
| 87428 | 0% | 912 | $0.00 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 0% | 502 | $0.00 |
| 90686 | 0% | 336 | $0.00 | |
| 90688 | 0% | 38 | $0.00 | |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | 0% | 145 | $0.00 |
| 87430 | 0% | 164 | $0.00 | |
| 3074F | 0% | 535 | $0.00 | |
| 87088 | 0% | 19 | $0.00 | |
| 90651 | 0% | 55 | $0.00 | |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | 0% | 124 | $0.00 |
| 3080F | 0% | 140 | $0.00 | |
| 81001 | 0% | 50 | $0.00 | |
| 90696 | 0% | 14 | $0.00 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 0% | 43 | $0.00 |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 0% | 13 | $0.00 |
| 81025 | 0% | 498 | $0.00 | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 0% | 227 | $0.00 |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 0% | 13 | $0.00 |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 0% | 1,228 | $0.00 |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 0% | 468 | $0.00 |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 0% | 2,099 | $0.00 |
| 90472 | Immunization administration, each additional vaccine (list separately) | 0% | 445 | $0.00 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 0% | 634 | $0.00 |
| 99173 | 0% | 207 | $0.00 | |
| 81003 | 0% | 147 | $0.00 | |
| 99201 | 0% | 223 | $0.00 | |
| 90734 | 0% | 108 | $0.00 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 0% | 109 | $0.00 |
| 80348 | 0% | 80 | $0.00 | |
| 80061 | Lipid panel | 0% | 288 | $0.00 |
| 90710 | 0% | 37 | $0.00 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 0% | 645 | $0.00 |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 0% | 265 | $0.00 |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 0% | 294 | $0.00 |
| 3078F | 0% | 531 | $0.00 | |
| 3077F | 0% | 140 | $0.00 | |
| 99203 | Doctor's office visit, new patient (routine) | 0% | 49 | $0.00 |
| 90832 | Psychotherapy session, about 30 minutes | 0% | 148 | $0.00 |
| 90715 | 0% | 52 | $0.00 | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 0% | 17 | $0.00 |
| 90633 | 0% | 29 | $0.00 | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMITROKA, KIM (PRESIDENT CEO)
| Provider | Location | Paid |
|---|---|---|
| Christopher Greater Area Rural Health Planning Corporation | Christopher, IL | $16.82M |
| Christopher Greater Area Rural Health Planning Corporation | Mt Vernon, IL | $9.52M |
| Christopher Greater Area Rural Health Planning Corporation | Johnston City, IL | $4.42M |
| Christopher Greater Area Rural Health Planning Corporation | Eldorado, IL | $4.25M |
| Christopher Greater Area Rural Health Planning Corp | Flora, IL | $1.94M |
| Christopher Greater Area Rural Health Planning Corporation | Christopher, IL | $1.80M |
| Christopher Greater Area Rural Health Planning Corporation | Sesser, IL | $544K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.